U.S. Residential REITs Stock News

NYSE:PEN
NYSE:PENMedical Equipment

Should Penumbra’s RED 68 Catheter Recall and Margin Strain Require Action From Penumbra (PEN) Investors?

Penumbra, Inc. recently initiated a voluntary Class II recall of its Penumbra System RED 68 Reperfusion Catheter across multiple US states and international markets due to manufacturing issues that may cause catheter fractures, following firm notifications sent out in early June 2026. This recall comes shortly after Penumbra reported higher quarterly sales of US$390.05 million but lower net income of US$34.81 million and reduced earnings per share versus a year earlier, highlighting growing...
NasdaqGM:SION
NasdaqGM:SIONBiotechs

Why Sionna Therapeutics (SION) Is Down 90.9% After Ending SION-719 Add-On To Trikafta Therapy

Sionna Therapeutics recently reported that its Phase 2a PreciSION CF trial of NBD1 stabilizer SION-719 added to Trikafta did not improve sweat chloride levels, leading the company to discontinue SION-719 as an add-on therapy and to reassess its clinical plans. At the same time, early data from SION-451 combination studies and a cash balance of about US$268.3 million give Sionna room to reconsider how it pursues cystic fibrosis therapies while preserving capital. We’ll now examine how...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

3 AI And Data Analytics Stocks Worth Watching Right Now

As AI moves from buzzword to core toolkit for tracking inflation, jobs and growth in real time, investors are no longer limited to slow, revision prone government reports. That shift is creating a data gap between companies that power these new insights and everyone else, and missing it could mean missing the next big story. This article walks through three AI and data analytics stocks exposed to that news and explains why they stand out right now. The three stocks highlighted below are just...
NYSE:MD
NYSE:MDHealthcare

Pediatrix Medical Group (MD) Reported Higher Earnings, Is The Stock Fully Valued?

What triggered the latest move in Pediatrix Medical Group stock Pediatrix Medical Group (MD) is back in focus after reporting second quarter and first half 2026 results that showed higher sales, net income, and earnings per share from continuing operations compared with a year earlier. See our latest analysis for Pediatrix Medical Group. Pediatrix Medical Group's recent earnings release and addition to the Russell 2000 Defensive indexes come after a steady run, with a 90 day share price...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Upbound Group (UPBD) Dropped, So What Is Behind The Latest Move?

Upbound Group (UPBD) recently reported second quarter 2026 results and updated its outlook, which appears to be the key driver for the latest stock move as investors reassess earnings quality and guidance. See our latest analysis for Upbound Group. The latest move in Upbound Group's share price, which is down 3.08% over the last day at $19.22 and down 9.17% over the past month, comes after second quarter earnings, refined revenue guidance, and confirmation that the buyback program has now...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Is Akamai Technologies (AKAM) Undervalued Following Its Q2 Beat And $600 Million Cloud Deal?

Akamai Technologies (AKAM) has become a talking point after Q2 2026 results that topped expectations, anchored by a new multi year US$600 million cloud infrastructure deal and a growing focus on enterprise AI security. See our latest analysis for Akamai Technologies. Despite the earnings beat and new contracts, Akamai Technologies has seen its share price fall 21.34% over the past 90 days and 6.77% over the past 30 days, even as the year-to-date share price return is 38.25% and the 1-year...
NYSE:W
NYSE:WSpecialty Retail

Why Did Wayfair (W) Move Today?

Wayfair earnings and stock reaction Wayfair (W) is back in focus after its second quarter earnings on 4 August 2026, which showed higher sales, a very small net loss, stronger adjusted EBITDA and higher free cash flow. Investors also reacted to management's expectation for continued revenue growth, comments about market share gains and plans to expand the physical retail footprint, including a new Pittsburgh store scheduled to open in 2027. See our latest analysis for Wayfair. Wayfair's share...
NYSE:NPO
NYSE:NPOMachinery

Will Strong Q2 Results and Higher 2026 Guidance Change Enpro's (NPO) Advanced-Tech Narrative?

Enpro Inc. reported its second-quarter 2026 results, with sales rising to US$338.8 million and net income reaching US$27.1 million, while also affirming a quarterly dividend of US$0.32 per share payable in September 2026. The company also raised its 2026 revenue growth outlook to a range of 14% to 16%, indicating increased confidence relative to its prior expectations. Now we’ll assess how Enpro’s higher 2026 revenue growth guidance may reshape the existing investment narrative built on...
NYSE:MMM
NYSE:MMMIndustrials

Should Explosion-Related Safety Verdicts And Litigation Exposure Require Action From 3M (MMM) Investors?

A Harris County jury recently ordered 3M to pay US$61.5 million to Houston homeowners for its role in the 2020 Watson Grinding & Manufacturing explosion, after finding failures in servicing the facility’s gas detection and alarm systems contributed to the disaster. This third successful bellwether trial in the multi-district litigation highlights how 3M’s service practices for safety systems can translate into substantial legal liabilities and community impact. We’ll now examine how this...
NYSE:FNF
NYSE:FNFInsurance

Higher Bond Yields Are Putting These U.S. Insurance Stocks In Focus

With U.S. bond yields at multi year highs, inflation still above the Fed’s target, and markets second guessing what comes next under Kevin Warsh, interest rate sensitivity is firmly back in focus. That mix creates both risk and potential opportunity for investors watching how insurance stocks react to higher real yields. This article explains how the news relates to insurers and highlights 3 stocks from the screener to watch closely. The three insurers covered next are just a sample from this...
NYSE:VTR
NYSE:VTRHealth Care REITs

Ventas (VTR) Could Be 7% Below Fair Value After Q2 Earnings Update

Why Ventas Stock Is Back in Focus After Q2 Earnings Ventas (VTR) drew fresh attention after releasing second quarter 2026 results, along with a higher senior housing investment target and a modestly raised full year earnings outlook, which together shaped recent investor sentiment. See our latest analysis for Ventas. Against this backdrop, Ventas shares closed at US$91.95 and have delivered an 18.91% year to date share price return. The 1 year total shareholder return of 37.65% and 3 year...
NYSE:AVTR
NYSE:AVTRLife Sciences

Margin Squeeze And Buybacks Might Change The Case For Investing In Avantor (AVTR)

Avantor, Inc. has reported its second-quarter and first-half 2026 results, with sales inching up to US$1,692.3 million and US$3,273.7 million respectively, while net income fell to US$38.1 million for the quarter and US$81.4 million for the half year compared with the same periods in 2025. Despite this earnings squeeze, Avantor’s previously announced share repurchase program remains largely executed at 6,629,063 shares bought back for US$74.97 million, offering a contrasting signal of...
NasdaqGS:ADTN
NasdaqGS:ADTNCommunications

3 Technology Hardware Stocks Retail Investors Are Watching As Chip Costs Rise

Rising chipflation and tight supply in servers and storage hardware are pulling future demand into today, as enterprises rush to lock in equipment before costs bite harder. That rush can create pricing power and margin pressure at the same time, which is exactly where opportunities often appear first. This article explains how the news affects three specific hardware stocks and why their exposure to this story matters for your portfolio watchlist. The stocks covered below are just a starting...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore (EVR) Senior Hire And Earnings Put Fair Value Back In Focus

Executive hire and recent results put Evercore in focus Evercore (EVR) has drawn fresh attention after appointing Dylan Tornay as senior managing director in its equity capital markets group, alongside recent quarterly earnings and a confirmed dividend declaration. Tornay joins from Citi with nearly 30 years of equity capital markets experience. He will focus on industrials and infrastructure, areas that may matter for investors watching how Evercore positions its advisory and capital markets...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

The Bull Case For ePlus (PLUS) Could Change Following Mixed Q1 FY27 Results And Capital Return Plans

In early August 2026, ePlus Inc. reported Q1 FY27 results showing revenue of US$649.11 million and lower net income of US$30.28 million year on year, while reiterating mid-single-digit growth guidance for fiscal 2027 and declaring a quarterly dividend of US$0.27 per share. Management also highlighted that a strong balance sheet is allowing ePlus to keep funding organic growth, evaluate acquisitions, and return cash to shareholders through dividends and share repurchases, offering a mixed...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

Improved Losses Amid Weaker Revenue Might Change The Case For Investing In Diversified Healthcare Trust (DHC)

Diversified Healthcare Trust recently reported past second-quarter 2026 results, with sales of US$47.47 million and revenue of US$365.39 million, alongside a net loss of US$37.42 million and basic loss per share from continuing operations of US$0.16. Despite lower sales and revenue versus a year earlier, the trust reduced its net loss and loss per share, indicating that expense controls and operational adjustments are limiting the impact of softer top-line performance. We’ll now examine how...
NYSE:SXI
NYSE:SXIMachinery

Standex International (SXI) Earnings And FY27 Outlook Put Valuation Back In Focus

Standex International (SXI) has moved into focus after reporting higher quarterly and full year sales and net income, alongside guidance that points to further organic growth and an expanded new product pipeline in fiscal 2027. See our latest analysis for Standex International. Against this backdrop, Standex International's share price has climbed strongly, with a 90 day share price return of 28.68% and a year to date share price return of 45.93%. The 1 year total shareholder return of 75.26%...
NYSE:TDY
NYSE:TDYElectronic

Is Teledyne Technologies (TDY) Fairly Valued As It Buys Varex Imaging?

Teledyne Technologies (TDY) has agreed to acquire Varex Imaging in an all cash transaction valued at about US$1.1b, offering US$18.90 per Varex share. This move adds oncology focused X-ray detectors to Teledyne's portfolio. See our latest analysis for Teledyne Technologies. At a share price of US$690.25, Teledyne Technologies has posted a 30 day share price return of 8.77% and a year to date share price return of 33.06%. The 3 year total shareholder return of 71.49% points to sustained...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Oruka Therapeutics (ORKA) On Its Earnings Miss And Whether The Valuation Still Holds

Oruka Therapeutics (ORKA) drew investor attention on August 10 after reporting second quarter 2026 results that showed a wider loss per share than consensus expectations as the company continues funding its clinical pipeline. See our latest analysis for Oruka Therapeutics. The earnings miss has arrived after a strong run in Oruka Therapeutics' stock, with the latest share price at $105.14 and a year to date share price return of 271.91%. Over the past year, total shareholder return is very...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Intellia Therapeutics (NTLA) Could Be 50% Undervalued After Its Q2 2026 Earnings

Intellia Therapeutics (NTLA) reported Q2 2026 results that kept the company in loss making territory, although the net loss and loss per share for both the quarter and first half improved versus last year. See our latest analysis for Intellia Therapeutics. Intellia Therapeutics’ latest earnings release on 6 August came after a period where the stock’s year to date share price return of 30.51% is set against a 1 year total shareholder return of 11.92% and a 3 year total shareholder return that...
NYSE:EIX
NYSE:EIXElectric Utilities

Why Edison International (EIX) Is Getting Attention Today

Edison International earnings and guidance update Edison International (EIX) has released second quarter 2026 results that combine higher quarterly net income with revised, lower full year earnings guidance, giving investors fresh numbers to assess the stock. See our latest analysis for Edison International. The share price reaction around the earnings release has been weak, with Edison International down 5.1% over the past week and 9.8% over the past month, even though the year to date share...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy (EE) Could Be 17% Undervalued Following Strong Q2 Results And Dividend Hike

Excelerate Energy (EE) just reported second quarter 2026 earnings that show higher revenue and net income than the same period last year, alongside a 13% dividend increase that is drawing fresh attention to the stock. See our latest analysis for Excelerate Energy. Excelerate Energy’s recent earnings and dividend announcement come after a mixed stretch for the stock, with the share price up 25.3% year to date but easing over the past month, while the 1 year total shareholder return of 50.75%...
NYSE:NABL
NYSE:NABLSoftware

N-able (NABL) Is Down 36.6% After Lowering 2026 Revenue Guidance Amid Segment Renewal Pressure

N-able, Inc. recently reported its Q2 2026 results, shifting from a net loss of US$4.63 million a year ago to net income of US$1.76 million and issuing Q3 and full-year 2026 revenue guidance of US$134.5–US$135.5 million and US$539–US$542 million, respectively. Management highlighted Data Protection as a key driver of new annual recurring revenue and credited AI-generated code, now almost half of committed code, for improving development productivity, even as weaker renewal rates in UEM and...